Lansoprazolo Abc

Lansoprazole, the active ingredient in Lansoprazolo Abc, is a proton pump inhibitor presented as an unspecified/tablet for oral use. It reduces gastric acid secretion and is used to treat acid‑related disorders such as GERD, peptic ulcer disease and Zollinger‑Ellison syndrome. GNH USA supplies Lansoprazolo Abc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazolo Abc, a proton pump inhibitor, acts on conditions caused by excess gastric acid. - Gastroesophageal reflux disease (GERD): relieves heartburn and esophageal irritation. - Peptic ulcer disease: promotes healing of gastric and duodenal ulcers. - Helicobacter pylori eradication (in combination therapy): enhances antibiotic effectiveness to eradicate infection. - Zollinger‑Ellison syndrome: controls hyper‑secretion of gastric acid in this rare endocrine disorder.

Lansoprazolo Abc may cause a range of adverse reactions.

Common Side Effects: - Headache: mild to moderate pain in the head region. - Diarrhea: loose, watery stools occurring intermittently. - Nausea: feeling of unease or urge to vomit. - Abdominal pain: discomfort or cramping in the stomach area. - Flatulence: excess gas causing bloating. - Constipation: difficulty passing stools.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis with watery diarrhea. - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Elevated liver enzymes: signs of hepatic stress. - Stevens‑Johnson syndrome: serious skin and mucous membrane disorder. - Interstitial nephritis: kidney inflammation. - Hypomagnesemia: low magnesium levels causing muscle cramps or arrhythmias.

Before prescribing Lansoprazolo Abc, consider the following safety measures. - Renal function assessment: evaluate kidney health, especially in patients with impairment. - Hepatic monitoring: check liver enzymes periodically during long‑term therapy. - CYP2C19 interaction review: consider reduced metabolism in poor metabolizers. - Elderly caution: start with the lowest effective dose and monitor for adverse effects. - Discontinuation strategy: avoid abrupt cessation after prolonged use to prevent rebound acid hypersecretion. - Store at below 25°C: keep in the original pack, protect from moisture.

Lansoprazolo Abc can affect the plasma levels of several concomitant medicines.

Major Interactions (Avoid): - Clarithromycin: increased risk of elevated lansoprazole levels. - Ketoconazole: reduced absorption of the antifungal. - Atazanavir: decreased antiviral efficacy due to higher gastric pH. - HIV protease inhibitors (e.g., ritonavir): altered drug exposure.

Moderate Interactions (Monitor Closely): - Phenytoin: decreased phenytoin concentrations. - Rifampin: reduced lansoprazole effectiveness. - Methotrexate: increased risk of toxicity. - Digoxin: potential increase in serum digoxin levels. - Warfarin: possible alteration of anticoagulant effect.